C10ORF12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.318800E-01
Normal-vs-Stage2
7.209600E-01
Normal-vs-Stage3
5.119400E-01
Normal-vs-Stage4
2.273200E-01
Stage1-vs-Stage2
2.344800E-01
Stage1-vs-Stage3
9.044200E-01
Stage1-vs-Stage4
3.943600E-02
Stage2-vs-Stage3
2.884600E-01
Stage2-vs-Stage4
1.910800E-01
Stage3-vs-Stage4
9.724000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.251400E-01
Normal-vs-AfricanAmerican
7.383400E-01
Normal-vs-Asian
9.292600E-01
Caucasian-vs-AfricanAmerican
8.289600E-01
Caucasian-vs-Asian
5.454000E-01
AfricanAmerican-vs-Asian
6.214000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.793800E-01
Normal-vs-Female
8.771400E-01
Male-vs-Female
6.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.678400E-01
Normal-vs-Age(41-60Yrs)
4.551000E-01
Normal-vs-Age(61-80Yrs)
9.792400E-01
Normal-vs-Age(81-100Yrs)
6.789400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.343800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.749800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.669600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.879600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.694200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.181000E-01
Normal-vs-Daily Drinker
8.758600E-01
Normal-vs-Weekly Drinker
9.024200E-01
Normal-vs-Occasional Drinker
5.399200E-01
Normal-vs-Social Drinker
8.082200E-01
Non Drinker-vs-Daily Drinker
5.896200E-01
Non Drinker-vs-Weekly Drinker
6.922200E-01
Non Drinker-vs-Occasional Drinker
3.226000E-01
Non Drinker-vs-Social Drinker
8.688400E-01
Daily Drinker-vs-Weekly Drinker
9.290800E-01
Daily Drinker-vs-Occasional Drinker
1.498160E-01
Daily Drinker-vs-Social Drinker
4.996600E-01
Weekly Drinker-vs-Occasional Drinker
2.018800E-01
Weekly Drinker-vs-Social Drinker
5.570000E-01
Occasional Drinker-vs-Social Drinker
4.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.021000E-01
Normal-vs-Grade 2
7.544200E-02
Normal-vs-Grade 3
3.633800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.053600E-02
Grade 1-vs-Grade 3
3.358900E-03
Grade 1-vs-Grade 4
3.021000E-01
Grade 2-vs-Grade 3
2.799900E-02
Grade 2-vs-Grade 4
7.544200E-02
Grade 3-vs-Grade 4
3.633800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.306800E-01
Normal-vs-NonDiabetic
9.095800E-01
Diabetic-vs-NonDiabetic
9.346000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.913800E-01
Normal-vs-NoPancreatitis
9.201600E-01
Pancreatitis-vs-NoPancreatitis
2.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.548800E-01
Normal-vs-N1
7.337200E-01
N0-vs-N1
3.144600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.248600E-01
Normal-vs-TP53-NonMutant
9.552000E-01
TP53-Mutant-vs-TP53-NonMutant
3.420800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
